Sagimet Biosciences Inc.SGMTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-51M

-12.0% YoY

Free Cash Flow

$-46M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	2	0	0
Gross Profit	0	0	2	0	0
Operating Income	-24	-31↓30.9%	-31↑1.0%	-54↓77.1%	-57↓4.5%
Net Income	-24	-30↓24.8%	-28↑8.6%	-46↓63.5%	-51↓12.0%
EBITDA	-24	-31↓30.9%	-31↑1.0%	-46↓48.2%	-57↓24.8%
EPS Diluted	-1.10	-1.38↓25.5%	-1.53↓10.9%	-1.45↑5.2%	-1.58↓9.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	57	0↓99.7%	75↑47456.3%	76↑0.9%	35↓53.8%
Total Current Assets	59	33↓44.1%	97↑194.7%	153↑58.1%	116↓23.8%
Total Assets	59	33↓44.0%	97↑192.8%	160↑65.7%	116↓27.3%
Total Current Liabilities	2	5↑116.4%	6↑7.1%	4↓21.2%	5↑14.5%
Total Liabilities	217	220↑1.2%	6↓97.4%	4↓21.2%	5↑14.5%
Total Equity	-158	-187↓18.1%	91↑148.7%	156↑71.1%	111↓28.5%
Total Debt	0	0↓39.4%	0↓69.2%	0↑20.0%	0↓0.0%
Net Debt	-56	0↑100.1%	-75↓141749.1%	-76↓0.9%	-35↑53.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-22	-24↓12.8%	-24↑3.0%	-42↓78.6%	-46↓7.6%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-22	-24↓12.8%	-24↑3.0%	-42↓78.6%	-46↓7.6%
Stock-Based Comp	2	2↓1.3%	5↑165.4%	5↑6.0%	6↑22.0%
Net Change in Cash	-12	-57↓372.6%	75↑232.5%	1↓99.1%	-41↓5923.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance